[
    "{\"step_by_step_thinking\": \"Document 0 states that financial incentives for smoking cessation in pregnancy are highly cost-effective, with an incremental cost per quality-adjusted life years of \u00a3482, which is well below recommended decision thresholds. Document 1 also supports the efficacy and cost-effectiveness of financial incentives for smoking cessation among pregnant women. Document 13 also provides evidence that financial incentives are cost-effective for smoking cessation in low-income pregnant women. Document 16 also supports the cost-effectiveness of financial incentives for smoking cessation during pregnancy. Document 18 also supports the cost-effectiveness of financial incentives for smoking cessation during pregnancy. Document 19 also supports the cost-effectiveness of financial incentives for smoking cessation during pregnancy. Document 21 also supports the cost-effectiveness of financial incentives for smoking cessation during pregnancy. Document 22 also supports the cost-effectiveness of financial incentives for smoking cessation during pregnancy. Document 24 also supports the cost-effectiveness of financial incentives for smoking cessation during pregnancy. Document 26 also supports the cost-effectiveness of financial incentives for smoking cessation during pregnancy. Document 27 also supports the cost-effectiveness of financial incentives for smoking cessation during pregnancy. Document 28 also supports the cost-effectiveness of financial incentives for smoking cessation during pregnancy. Document 29 also supports the cost-effectiveness of financial incentives for smoking cessation during pregnancy. Document 30 also supports the cost-effectiveness of financial incentives for smoking cessation during pregnancy. Document 31 also supports the cost-effectiveness of financial incentives for smoking cessation during pregnancy.\", \"answer_choice\": \"A\"}"
]